| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,251,588 |
|
|
|
Indirect Value
|
$147,991,530 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$149,243,118 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-04-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
265,333 |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-11-14 |
4 |
AS |
$68.86 |
$6,197,292 |
D/D |
(90,000) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-12-16 |
4 |
AS |
$71.75 |
$6,457,941 |
D/D |
(90,000) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-01-14 |
4 |
AS |
$73.60 |
$6,681,147 |
D/D |
(90,000) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-02-15 |
4 |
S |
$33.12 |
$212,166 |
I/I |
(6,400) |
800 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2010-11-08 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,275 |
1,519 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-11-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,600 |
6,794 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-11-12 |
4 |
S |
$47.16 |
$94,319 |
I/I |
(2,000) |
12,394 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,558 |
12,453 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
12,793 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-05-21 |
4 |
S |
$42.64 |
$1,279,341 |
I/I |
(30,000) |
14,394 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
16,000 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,393 |
19,602 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
22,287 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
D |
$70.31 |
$497,092 |
D/D |
(7,070) |
24,011 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-01-30 |
5 |
A |
$0.00 |
$0 |
D/D |
26,666 |
26,666 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
D |
$80.69 |
$570,559 |
D/D |
(7,071) |
28,995 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,794 |
31,081 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
23,273 |
36,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-11-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
44,394 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
250 |
47,036 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
250 |
47,286 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2003-10-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
500 |
47,536 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-11-07 |
4 |
S |
$44.75 |
$1,790,000 |
I/I |
(40,000) |
49,394 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
41,458 |
68,124 |
0 |
- |
|
193 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
